

A provider's guide to helping patients find Ciprofloxacin/Dexamethasone (Ciprodex) ear drops in stock. Five actionable steps and alternative options.
You've diagnosed an ear infection, prescribed Ciprofloxacin/Dexamethasone otic suspension, and sent your patient on their way. Then you get a call — or a message through the portal — saying their pharmacy doesn't have it. It's a scenario that plays out more often than it should, and it can delay treatment for a condition that causes real discomfort.
This guide provides a practical workflow for helping patients locate Ciprofloxacin/Dexamethasone (brand name Ciprodex) when their initial pharmacy comes up empty, along with clinical alternatives and cost-saving strategies you can integrate into your prescribing practice.
Ciprofloxacin/Dexamethasone 0.3%/0.1% otic suspension is not currently listed on the FDA drug shortage database. The overall supply has improved substantially since the first generic launch by Dr. Reddy's Laboratories in March 2023, followed by additional manufacturers including Upsher-Smith.
However, localized availability issues persist due to:
For a full analysis of the supply situation, see our provider shortage briefing.
From the patient's perspective, the typical experience goes like this:
This cycle can consume hours of a patient's time and delay treatment initiation. For pediatric patients with ear tubes who may be in significant discomfort, even a one-day delay is clinically meaningful. Proactive steps at the point of prescribing can prevent much of this frustration.
Write prescriptions for "Ciprofloxacin/Dexamethasone 0.3%/0.1% otic suspension" rather than "Ciprodex." This gives the pharmacy maximum dispensing flexibility. They can fill it with brand-name Ciprodex, Dr. Reddy's generic, Upsher-Smith generic, or any other FDA-approved equivalent — whichever they have on the shelf.
Before the patient leaves your office, mention that if their pharmacy doesn't have it, they can check medfinder.com to find nearby pharmacies with current stock. This single step can save patients hours of phone calls and reduce callback volume to your office.
Consider adding medfinder.com/providers to your after-visit summary or patient handouts for commonly shorted medications.
At the point of prescribing, consider proactively telling the patient: "If the pharmacy doesn't have this, call us and we can prescribe an alternative the same day." This sets expectations and reduces anxiety.
Clinically appropriate alternatives include:
For detailed clinical comparisons, see our alternatives guide.
Price is a common reason patients don't fill otic prescriptions. Brand-name Ciprodex costs $260–$350 without insurance — a significant barrier for many families. Proactive cost conversations can improve adherence:
For a comprehensive savings guide to share with patients, see how to save money on Ciprofloxacin/Dexamethasone.
If a patient finds the medication at a different pharmacy, remind them (or your staff) that prescription transfers are routine and typically take only a few minutes. Either the sending or receiving pharmacy can initiate the transfer. For e-prescriptions, you can also send a new prescription directly to the pharmacy that has stock.
A quick clinical reference for common scenarios:
Ciprofloxacin/Dexamethasone is a valuable medication that most patients can access with a little guidance. By prescribing generically, directing patients to availability tools like Medfinder, having alternatives ready, and proactively addressing cost, you can minimize treatment delays and reduce the administrative burden on your practice.
For more on the current supply landscape, see our shortage briefing for providers. For a patient-facing version of this information, share our guide on how to find Ciprofloxacin/Dexamethasone in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.